Immunopharmacol., 1(3):
399-414 (1979).
7. Grassl, E.D. et al., Fibrin as an alternative
biopolymer to type-I collagen for the fabrication
of a media equivalent. J. Biomed. Mater. Res.,
60(4): 607-612 (2002
Immunopharmacol., 1(3):
399-414 (1979).
7. Grassl, E.D. et al., Fibrin as an alternative
biopolymer to type-I collagen for the fabrication
of a media equivalent. J. Biomed. Mater. Res.,
60(4): 607-612 (2002
FGFR1 (FLT2) (399-822) Active (F5055) - Datasheet
FGFR1 (FLT2) (399-822), active, GST-tagged, human
Precisio Kinase
recombinant, expressed in Sf9 cells
Catalog Number F5055
Lot Number 040M0726
FGFR1 (FLT2) (399-822) Active (F5055) - Datasheet
FGFR1 (FLT2) (399-822) Active
human, recombinant
GST-tagged, expressed in Sf9 cells
Catalog Number F5055
Lot Number 019K1576
Storage Temperature
FGFR1 (FLT2) (399-822), active (F5055) - Datasheet
FGFR1 (FLT2) (399-822), active, GST-tagged, human
PRECISIO Kinase
recombinant, expressed in Sf9 cells
Catalog Number F5055
Lot Number 110M0863
FGFR1 (FLT2) (399-822) Active (F5055) - Datasheet
FGFR1 (FLT2) (399-822), active, GST-tagged, human
Precisio Kinase
recombinant, expressed in Sf9 cells
Catalog Number F5055
Lot Number 040M0736
pseudopentapeptide containing a thiomethylene
ether amide bond replacement. Int. J. Pept.
Protein Res., 36(4), 392-399 (1990).
GCY/RXR 7/03
Sigma brand products are sold through Sigma-Aldrich, Inc.
Sigma-
Immunopharmacol.,
1(3), 399-414 (1979).
7. Grassl, E. D., et al., Fibrin as an alternative
biopolymer to type-I collagen for the fabrication of
a media equivalent. J. Biomed. Mater. Res.,
60(4), 607-612 (2002
metalloproteinases 1 and rectal cancer patient
survival. a validation study. Eur. J. Cancer, 40, 64–
72 (2004).
4. Yoshikawa, T. et al., Intratumoral concentrations of
tissue inhibitor of matrix metalloproteinase
Immunopharmacol., 1(3), 399-414
(1979).
7. Grassl, E.D. et al., Fibrin as an alternative
biopolymer to type-I collagen for the fabrication of a
media equivalent. J. Biomed. Mater. Res., 60(4),
607-612 (2002
metalloproteinases 1 and rectal cancer patient
survival. a validation study. Eur. J. Cancer, 40, 64–
72 (2004).
4. Yoshikawa, T. et al., Intratumoral concentrations of
tissue inhibitor of matrix metalloproteinase
induces apoptosis
and inhibits growth of pancreatic cancer cells, .Int.
J. Cancer, 86, 399-407 (2000)
4. Martindale: The Extra Pharmacopoeia, 30th ed.,
Reynolds, J.E.F., Ed., 473 (1993).
5.
of phylogenetically distinct enterococcal species and species groups. J. Appl.
Bacteriol. 75: 399-408.
Pharmacopoeia of Culture Media for Food Microbiology (1987): Int. J. Food Microbiol. 5: 214
induces apoptosis
and inhibits growth of pancreatic cancer cells, .Int.
J. Cancer, 86, 399-407 (2000)
4. Martindale: The Extra Pharmacopoeia, 30th ed.,
Reynolds, J.E.F., Ed., 473 (1993).
5.
induces apoptosis
and inhibits growth of pancreatic cancer cells, .Int.
J. Cancer, 86, 399-407 (2000)
4. Martindale: The Extra Pharmacopoeia, 30th ed.,
Reynolds, J.E.F., Ed., 473 (1993).
5.
induces apoptosis
and inhibits growth of pancreatic cancer cells, .Int.
J. Cancer, 86, 399-407 (2000)
4. Martindale: The Extra Pharmacopoeia, 30th ed.,
Reynolds, J.E.F., Ed., 473 (1993).
5.
html
4. K. Breitruck, K. Feige. Bromatbestimmung in Wasser und Trinkwasser., FOOD-Lab International, 2012;1/12: 28–31.
https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/399/605/
modification by CRISPR-Cas9 nickase with minimal off-
target effects. Nature Methods 11, 399–402 (2014)
4. Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome
editing
modification by CRISPR-Cas9 nickase with minimal off-
target effects. Nature Methods 11, 399–402 (2014)
4. Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome
editing
modification by CRISPR-Cas9 nickase with minimal off-
target effects. Nature Methods 11, 399–402 (2014)
4. Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome
editing
Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its roles in the